Indazoles of cyclic ureas useful as hiv protease inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/06 (2006.01) A61K 31/55 (2006.01) A61K 31/551 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 417/14 (2006.01) C07D 491/04 (2006.01) C07D 521/00 (2006.01)

Patent

CA 2282593

The present invention describes indazoles of cyclic ureas of formula (I): wherein X is a linker group and Y may be acyclic or cyclic, which are useful as inhibitors of HIV protease, and pharmaceutical compositions and diagnostic kits comprising the same. One of D and D' is NH2 and the other selected from H, haloges, C1-6 alkoxy and C1-6 alygl.

La présente invention concerne des indazoles d'urées cycliques représentés par la formule (I), dans laquelle X est un groupe lieur, Y peut être acyclique ou cyclique, et l'un des deux éléments que sont D et D' est NH2, l'autre étant selectionné parmi H, un halogène, un groupe alcoxy C1-6 et un groupe alkyle C1-6 ces indazoles étant utiles comme inhibiteurs de VIH protéase. L'invention concerne des compositions pharmaceutiques et des trousses diagnostiques comportant celles-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Indazoles of cyclic ureas useful as hiv protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indazoles of cyclic ureas useful as hiv protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazoles of cyclic ureas useful as hiv protease inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1483721

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.